1. Home
  2. LUNG vs POLE Comparison

LUNG vs POLE Comparison

Compare LUNG & POLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • POLE
  • Stock Information
  • Founded
  • LUNG 1995
  • POLE 2024
  • Country
  • LUNG United States
  • POLE United States
  • Employees
  • LUNG N/A
  • POLE N/A
  • Industry
  • LUNG Industrial Specialties
  • POLE
  • Sector
  • LUNG Health Care
  • POLE
  • Exchange
  • LUNG Nasdaq
  • POLE NYSE
  • Market Cap
  • LUNG 299.3M
  • POLE 296.0M
  • IPO Year
  • LUNG 2020
  • POLE 2024
  • Fundamental
  • Price
  • LUNG $7.97
  • POLE $10.11
  • Analyst Decision
  • LUNG Strong Buy
  • POLE
  • Analyst Count
  • LUNG 7
  • POLE 0
  • Target Price
  • LUNG $12.64
  • POLE N/A
  • AVG Volume (30 Days)
  • LUNG 486.4K
  • POLE 3.8K
  • Earning Date
  • LUNG 04-30-2025
  • POLE 01-01-0001
  • Dividend Yield
  • LUNG N/A
  • POLE N/A
  • EPS Growth
  • LUNG N/A
  • POLE N/A
  • EPS
  • LUNG N/A
  • POLE N/A
  • Revenue
  • LUNG $83,789,000.00
  • POLE N/A
  • Revenue This Year
  • LUNG $17.96
  • POLE N/A
  • Revenue Next Year
  • LUNG $18.35
  • POLE N/A
  • P/E Ratio
  • LUNG N/A
  • POLE N/A
  • Revenue Growth
  • LUNG 22.01
  • POLE N/A
  • 52 Week Low
  • LUNG $5.46
  • POLE $9.94
  • 52 Week High
  • LUNG $10.01
  • POLE $11.16
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 55.35
  • POLE N/A
  • Support Level
  • LUNG $6.97
  • POLE N/A
  • Resistance Level
  • LUNG $7.65
  • POLE N/A
  • Average True Range (ATR)
  • LUNG 0.63
  • POLE 0.00
  • MACD
  • LUNG -0.09
  • POLE 0.00
  • Stochastic Oscillator
  • LUNG 42.55
  • POLE 0.00

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About POLE ANDRETTI ACQUISITION CORP. II

Andretti Acquisition Corp II is a blank check company.

Share on Social Networks: